The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism
- Autores
- Sebastián, Carlos; Zwaans, Bernardette M. M.; Silberman, Dafne Magali; Gymrek, Melissa; Goren, Alon; Zhong, Lei; Ram, Oren; Truelove, Jessica; Guimaraes, Alexander R.; Toiber, Debra; Cosentino, Claudia; Greenson, Joel K.; MacDonald, Alasdair I.; McGlynn, Liane; Maxwell, Fraser; Edwards, Joanne; Giacosa, Sofía; Guccione, Ernesto; Weissleder, Ralph; Bernstein, Bradley E.; Regev, Aviv; Shiels, Paul G.; Lombard, David B.; Mostoslavsky, Raul
- Año de publicación
- 2012
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Reprogramming of cellular metabolism is a key event during tumorigenesis. Despite being known for decades (Warburg effect), the molecular mechanisms regulating this switch remained unexplored. Here, we identify SIRT6 as a tumor suppressor that regulates aerobic glycolysis in cancer cells. Importantly, loss of SIRT6 leads to tumor formation without activation of known oncogenes, whereas transformed SIRT6-deficient cells display increased glycolysis and tumor growth, suggesting that SIRT6 plays a role in both establishment and maintenance of cancer. By using a conditional SIRT6 allele, we show that SIRT6 deletion in vivo increases the number, size, and aggressiveness of tumors. SIRT6 also functions as a regulator of ribosome metabolism by corepressing MYC transcriptional activity. Lastly, Sirt6 is selectively downregulated in several human cancers, and expression levels of SIRT6 predict prognosis and tumor-free survival rates, highlighting SIRT6 as a critical modulator of cancer metabolism. Our studies reveal SIRT6 to be a potent tumor suppressor acting to suppress cancer metabolism.
Fil: Sebastián, Carlos. Harvard Medical School; Estados Unidos
Fil: Zwaans, Bernardette M. M.. University of Michigan; Estados Unidos
Fil: Silberman, Dafne Magali. Harvard Medical School; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Centro de Estudios Farmacológicos y Botánicos. Universidad de Buenos Aires. Facultad de Medicina. Centro de Estudios Farmacológicos y Botánicos; Argentina
Fil: Gymrek, Melissa. Massachusetts Institute of Technology; Estados Unidos
Fil: Goren, Alon. Harvard Medical School; Estados Unidos. Massachusetts Institute of Technology; Estados Unidos
Fil: Zhong, Lei. Harvard Medical School; Estados Unidos
Fil: Ram, Oren. Harvard Medical School; Estados Unidos. Massachusetts Institute of Technology; Estados Unidos
Fil: Truelove, Jessica. The Massachusetts General Hospital; Estados Unidos
Fil: Guimaraes, Alexander R.. The Massachusetts General Hospital; Estados Unidos
Fil: Toiber, Debra. Harvard Medical School; Estados Unidos
Fil: Cosentino, Claudia. Harvard Medical School; Estados Unidos
Fil: Greenson, Joel K.. University of Michigan; Estados Unidos
Fil: MacDonald, Alasdair I.. University of Glasgow; Reino Unido
Fil: McGlynn, Liane. University of Glasgow; Reino Unido
Fil: Maxwell, Fraser. University of Glasgow; Reino Unido
Fil: Edwards, Joanne. University of Glasgow; Reino Unido
Fil: Giacosa, Sofía. Harvard Medical School; Estados Unidos
Fil: Guccione, Ernesto. Institute of Molecular and Cell Biology; Singapur
Fil: Weissleder, Ralph. The Massachusetts General Hospital; Estados Unidos
Fil: Bernstein, Bradley E.. Harvard Medical School; Estados Unidos
Fil: Regev, Aviv. Harvard Medical School; Estados Unidos
Fil: Shiels, Paul G.. University of Glasgow; Reino Unido
Fil: Lombard, David B.. University of Michigan; Estados Unidos
Fil: Mostoslavsky, Raul. Harvard Medical School; Estados Unidos - Materia
-
Sirt6
Cancer
Metabolism - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/17712
Ver los metadatos del registro completo
id |
CONICETDig_6920e5524884f257c9eaac41ee8685ec |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/17712 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolismSebastián, CarlosZwaans, Bernardette M. M.Silberman, Dafne MagaliGymrek, MelissaGoren, AlonZhong, LeiRam, OrenTruelove, JessicaGuimaraes, Alexander R.Toiber, DebraCosentino, ClaudiaGreenson, Joel K.MacDonald, Alasdair I.McGlynn, LianeMaxwell, FraserEdwards, JoanneGiacosa, SofíaGuccione, ErnestoWeissleder, RalphBernstein, Bradley E.Regev, AvivShiels, Paul G.Lombard, David B.Mostoslavsky, RaulSirt6CancerMetabolismhttps://purl.org/becyt/ford/3.3https://purl.org/becyt/ford/3Reprogramming of cellular metabolism is a key event during tumorigenesis. Despite being known for decades (Warburg effect), the molecular mechanisms regulating this switch remained unexplored. Here, we identify SIRT6 as a tumor suppressor that regulates aerobic glycolysis in cancer cells. Importantly, loss of SIRT6 leads to tumor formation without activation of known oncogenes, whereas transformed SIRT6-deficient cells display increased glycolysis and tumor growth, suggesting that SIRT6 plays a role in both establishment and maintenance of cancer. By using a conditional SIRT6 allele, we show that SIRT6 deletion in vivo increases the number, size, and aggressiveness of tumors. SIRT6 also functions as a regulator of ribosome metabolism by corepressing MYC transcriptional activity. Lastly, Sirt6 is selectively downregulated in several human cancers, and expression levels of SIRT6 predict prognosis and tumor-free survival rates, highlighting SIRT6 as a critical modulator of cancer metabolism. Our studies reveal SIRT6 to be a potent tumor suppressor acting to suppress cancer metabolism.Fil: Sebastián, Carlos. Harvard Medical School; Estados UnidosFil: Zwaans, Bernardette M. M.. University of Michigan; Estados UnidosFil: Silberman, Dafne Magali. Harvard Medical School; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Centro de Estudios Farmacológicos y Botánicos. Universidad de Buenos Aires. Facultad de Medicina. Centro de Estudios Farmacológicos y Botánicos; ArgentinaFil: Gymrek, Melissa. Massachusetts Institute of Technology; Estados UnidosFil: Goren, Alon. Harvard Medical School; Estados Unidos. Massachusetts Institute of Technology; Estados UnidosFil: Zhong, Lei. Harvard Medical School; Estados UnidosFil: Ram, Oren. Harvard Medical School; Estados Unidos. Massachusetts Institute of Technology; Estados UnidosFil: Truelove, Jessica. The Massachusetts General Hospital; Estados UnidosFil: Guimaraes, Alexander R.. The Massachusetts General Hospital; Estados UnidosFil: Toiber, Debra. Harvard Medical School; Estados UnidosFil: Cosentino, Claudia. Harvard Medical School; Estados UnidosFil: Greenson, Joel K.. University of Michigan; Estados UnidosFil: MacDonald, Alasdair I.. University of Glasgow; Reino UnidoFil: McGlynn, Liane. University of Glasgow; Reino UnidoFil: Maxwell, Fraser. University of Glasgow; Reino UnidoFil: Edwards, Joanne. University of Glasgow; Reino UnidoFil: Giacosa, Sofía. Harvard Medical School; Estados UnidosFil: Guccione, Ernesto. Institute of Molecular and Cell Biology; SingapurFil: Weissleder, Ralph. The Massachusetts General Hospital; Estados UnidosFil: Bernstein, Bradley E.. Harvard Medical School; Estados UnidosFil: Regev, Aviv. Harvard Medical School; Estados UnidosFil: Shiels, Paul G.. University of Glasgow; Reino UnidoFil: Lombard, David B.. University of Michigan; Estados UnidosFil: Mostoslavsky, Raul. Harvard Medical School; Estados UnidosElsevier2012-12info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/17712Sebastián, Carlos; Zwaans, Bernardette M. M.; Silberman, Dafne Magali; Gymrek, Melissa; Goren, Alon; et al.; The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism; Elsevier; Cell; 151; 6; 12-2012; 1185-11990092-8674enginfo:eu-repo/semantics/altIdentifier/url/http://www.sciencedirect.com/science/article/pii/S0092867412013517info:eu-repo/semantics/altIdentifier/doi/10.1016/j.cell.2012.10.047info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-nd/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T10:02:40Zoai:ri.conicet.gov.ar:11336/17712instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 10:02:41.075CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism |
title |
The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism |
spellingShingle |
The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism Sebastián, Carlos Sirt6 Cancer Metabolism |
title_short |
The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism |
title_full |
The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism |
title_fullStr |
The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism |
title_full_unstemmed |
The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism |
title_sort |
The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism |
dc.creator.none.fl_str_mv |
Sebastián, Carlos Zwaans, Bernardette M. M. Silberman, Dafne Magali Gymrek, Melissa Goren, Alon Zhong, Lei Ram, Oren Truelove, Jessica Guimaraes, Alexander R. Toiber, Debra Cosentino, Claudia Greenson, Joel K. MacDonald, Alasdair I. McGlynn, Liane Maxwell, Fraser Edwards, Joanne Giacosa, Sofía Guccione, Ernesto Weissleder, Ralph Bernstein, Bradley E. Regev, Aviv Shiels, Paul G. Lombard, David B. Mostoslavsky, Raul |
author |
Sebastián, Carlos |
author_facet |
Sebastián, Carlos Zwaans, Bernardette M. M. Silberman, Dafne Magali Gymrek, Melissa Goren, Alon Zhong, Lei Ram, Oren Truelove, Jessica Guimaraes, Alexander R. Toiber, Debra Cosentino, Claudia Greenson, Joel K. MacDonald, Alasdair I. McGlynn, Liane Maxwell, Fraser Edwards, Joanne Giacosa, Sofía Guccione, Ernesto Weissleder, Ralph Bernstein, Bradley E. Regev, Aviv Shiels, Paul G. Lombard, David B. Mostoslavsky, Raul |
author_role |
author |
author2 |
Zwaans, Bernardette M. M. Silberman, Dafne Magali Gymrek, Melissa Goren, Alon Zhong, Lei Ram, Oren Truelove, Jessica Guimaraes, Alexander R. Toiber, Debra Cosentino, Claudia Greenson, Joel K. MacDonald, Alasdair I. McGlynn, Liane Maxwell, Fraser Edwards, Joanne Giacosa, Sofía Guccione, Ernesto Weissleder, Ralph Bernstein, Bradley E. Regev, Aviv Shiels, Paul G. Lombard, David B. Mostoslavsky, Raul |
author2_role |
author author author author author author author author author author author author author author author author author author author author author author author |
dc.subject.none.fl_str_mv |
Sirt6 Cancer Metabolism |
topic |
Sirt6 Cancer Metabolism |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.3 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Reprogramming of cellular metabolism is a key event during tumorigenesis. Despite being known for decades (Warburg effect), the molecular mechanisms regulating this switch remained unexplored. Here, we identify SIRT6 as a tumor suppressor that regulates aerobic glycolysis in cancer cells. Importantly, loss of SIRT6 leads to tumor formation without activation of known oncogenes, whereas transformed SIRT6-deficient cells display increased glycolysis and tumor growth, suggesting that SIRT6 plays a role in both establishment and maintenance of cancer. By using a conditional SIRT6 allele, we show that SIRT6 deletion in vivo increases the number, size, and aggressiveness of tumors. SIRT6 also functions as a regulator of ribosome metabolism by corepressing MYC transcriptional activity. Lastly, Sirt6 is selectively downregulated in several human cancers, and expression levels of SIRT6 predict prognosis and tumor-free survival rates, highlighting SIRT6 as a critical modulator of cancer metabolism. Our studies reveal SIRT6 to be a potent tumor suppressor acting to suppress cancer metabolism. Fil: Sebastián, Carlos. Harvard Medical School; Estados Unidos Fil: Zwaans, Bernardette M. M.. University of Michigan; Estados Unidos Fil: Silberman, Dafne Magali. Harvard Medical School; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Centro de Estudios Farmacológicos y Botánicos. Universidad de Buenos Aires. Facultad de Medicina. Centro de Estudios Farmacológicos y Botánicos; Argentina Fil: Gymrek, Melissa. Massachusetts Institute of Technology; Estados Unidos Fil: Goren, Alon. Harvard Medical School; Estados Unidos. Massachusetts Institute of Technology; Estados Unidos Fil: Zhong, Lei. Harvard Medical School; Estados Unidos Fil: Ram, Oren. Harvard Medical School; Estados Unidos. Massachusetts Institute of Technology; Estados Unidos Fil: Truelove, Jessica. The Massachusetts General Hospital; Estados Unidos Fil: Guimaraes, Alexander R.. The Massachusetts General Hospital; Estados Unidos Fil: Toiber, Debra. Harvard Medical School; Estados Unidos Fil: Cosentino, Claudia. Harvard Medical School; Estados Unidos Fil: Greenson, Joel K.. University of Michigan; Estados Unidos Fil: MacDonald, Alasdair I.. University of Glasgow; Reino Unido Fil: McGlynn, Liane. University of Glasgow; Reino Unido Fil: Maxwell, Fraser. University of Glasgow; Reino Unido Fil: Edwards, Joanne. University of Glasgow; Reino Unido Fil: Giacosa, Sofía. Harvard Medical School; Estados Unidos Fil: Guccione, Ernesto. Institute of Molecular and Cell Biology; Singapur Fil: Weissleder, Ralph. The Massachusetts General Hospital; Estados Unidos Fil: Bernstein, Bradley E.. Harvard Medical School; Estados Unidos Fil: Regev, Aviv. Harvard Medical School; Estados Unidos Fil: Shiels, Paul G.. University of Glasgow; Reino Unido Fil: Lombard, David B.. University of Michigan; Estados Unidos Fil: Mostoslavsky, Raul. Harvard Medical School; Estados Unidos |
description |
Reprogramming of cellular metabolism is a key event during tumorigenesis. Despite being known for decades (Warburg effect), the molecular mechanisms regulating this switch remained unexplored. Here, we identify SIRT6 as a tumor suppressor that regulates aerobic glycolysis in cancer cells. Importantly, loss of SIRT6 leads to tumor formation without activation of known oncogenes, whereas transformed SIRT6-deficient cells display increased glycolysis and tumor growth, suggesting that SIRT6 plays a role in both establishment and maintenance of cancer. By using a conditional SIRT6 allele, we show that SIRT6 deletion in vivo increases the number, size, and aggressiveness of tumors. SIRT6 also functions as a regulator of ribosome metabolism by corepressing MYC transcriptional activity. Lastly, Sirt6 is selectively downregulated in several human cancers, and expression levels of SIRT6 predict prognosis and tumor-free survival rates, highlighting SIRT6 as a critical modulator of cancer metabolism. Our studies reveal SIRT6 to be a potent tumor suppressor acting to suppress cancer metabolism. |
publishDate |
2012 |
dc.date.none.fl_str_mv |
2012-12 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/17712 Sebastián, Carlos; Zwaans, Bernardette M. M.; Silberman, Dafne Magali; Gymrek, Melissa; Goren, Alon; et al.; The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism; Elsevier; Cell; 151; 6; 12-2012; 1185-1199 0092-8674 |
url |
http://hdl.handle.net/11336/17712 |
identifier_str_mv |
Sebastián, Carlos; Zwaans, Bernardette M. M.; Silberman, Dafne Magali; Gymrek, Melissa; Goren, Alon; et al.; The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism; Elsevier; Cell; 151; 6; 12-2012; 1185-1199 0092-8674 |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/http://www.sciencedirect.com/science/article/pii/S0092867412013517 info:eu-repo/semantics/altIdentifier/doi/10.1016/j.cell.2012.10.047 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Elsevier |
publisher.none.fl_str_mv |
Elsevier |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844613833554919424 |
score |
13.070432 |